ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$44.60
-1.58 (-3.42%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-73.3% upside
Low Target
$8.04
Average Target
$11.93
High Target
$13.91
Current Price
$44.60
Current
$44.60
$44.60
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Scenario Analysis
Bear Case
$8.04
-82.0%
Low target
Base Case
$11.93
-73.3%
Avg target
Bull Case
$13.91
+-68.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$50.18
-11.1% from high
52-Week Low
$14.27
+212.5% from low
Target vs 52W High
$11.93
-76.2% vs high
Next Earnings Report
Aug 13, 2026 · After Market Close
2d
until earnings
EPS Est: $0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |